1. МОНИТОРИНГ ЗА БЕЗОПАСНОСТ ПРИ ЛЕЧЕНИЕ НА ПАЦИЕНТИ С ХРОНИЧЕН ВЪЗПАЛИТЕЛЕН АРТРИТ С БИОЛОГИЧНИ АГЕНТИ.
- Author
-
Стоилова, С., Генева-Попова, М., Цигаровски, Г., and Милева-Николова, Д.
- Subjects
- *
ANTIRHEUMATIC agents , *PATIENT education , *PHYSICIANS , *RHEUMATOLOGY , *ARTHRITIS - Abstract
Safety monitoring identifies and evaluates potential side effects of the treatment in order to prevent the occurrence of future ones by improving the patient problem-solving abilities related to their safety. The use of biologic disease-modifying antirheumatic drugs is associated with recommendations for close disease monitoring. To ensure their safe implementation, the existing recommendations for the management of chronic inflammatory arthritis require monitoring of related safety issues, which can be overcome through patient education. Safety monitoring includes various aspects: to patients, on the one hand, and to specialized rheumatology team on the other (most commonly a physician, health care professional - nurse, etc.), as well as active involvement of primary care health professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2024